Autocrine motility factor and its receptor expression in musculoskeletal tumors

Management of aggressive malignant musculoskeletal tumors is clinically challenging and awaits the identification of regulator(s) that can be therapeutically used to improve patient outcome. Autocrine motility factor (AMF), a secreted cytokine, is known to alter the bone microenvironment by linking...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Kosei, Raz, Avraham
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574284/
https://www.ncbi.nlm.nih.gov/pubmed/33101887
http://dx.doi.org/10.1016/j.jbo.2020.100318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574284/
https://www.ncbi.nlm.nih.gov/pubmed/33101887
http://dx.doi.org/10.1016/j.jbo.2020.100318

Ejemplares similares